• Latest News
  • Antikor Advances Breakthrough Fragment Drug Conjugate (FDC) Technology

    13/11/2017 Antikor Biopharma Limited (Antikor), a leader in developing and advancing Antibody Fragment-Drug Conjugates (FDCs), will be presenting new data at the 9th Protein and Antibody Engineering Summit (PEGS) Europe in Lisbon on 14th November, 2017 ( www.pegsummiteurope.com ). Dr Deonarain, CEO and CSO will... read more


Funding Partners: